BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24925855)

  • 1. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.
    Halder SK; Sharan C; Al-Hendy O; Al-Hendy A
    Reprod Sci; 2014 Sep; 21(9):1108-19. PubMed ID: 24925855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.
    Combs A; Singh B; Nylander E; Islam MS; Nguyen HV; Parra E; Bello A; Segars J
    Reprod Sci; 2023 Apr; 30(4):1049-1064. PubMed ID: 35960442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
    Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
    Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
    Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
    Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vitamin D in uterine fibroid biology.
    Brakta S; Diamond JS; Al-Hendy A; Diamond MP; Halder SK
    Fertil Steril; 2015 Sep; 104(3):698-706. PubMed ID: 26079694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
    Al-Hendy A; Diamond MP; El-Sohemy A; Halder SK
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E572-82. PubMed ID: 25625804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation.
    Ciavattini A; Delli Carpini G; Serri M; Vignini A; Sabbatinelli J; Tozzi A; Aggiusti A; Clemente N
    Medicine (Baltimore); 2016 Dec; 95(52):e5698. PubMed ID: 28033263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids.
    Ciebiera M; Włodarczyk M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
    Fertil Steril; 2016 Dec; 106(7):1787-1792. PubMed ID: 27743697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.
    Al-Hendy A; Diamond MP; Boyer TG; Halder SK
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1542-51. PubMed ID: 26820714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.
    Borahay MA; Al-Hendy A; Kilic GS; Boehning D
    Mol Med; 2015 Apr; 21(1):242-56. PubMed ID: 25879625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary components and uterine leiomyomas: a review of published data.
    Parazzini F; Di Martino M; Candiani M; Viganò P
    Nutr Cancer; 2015; 67(4):569-79. PubMed ID: 25826470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids.
    Ciebiera M; Ali M; Prince L; Zgliczyński S; Jakiel G; Al-Hendy A
    Reprod Sci; 2021 Aug; 28(8):2098-2109. PubMed ID: 33108619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is vitamin D the answer for prevention of uterine fibroids?
    Wu JL; Segars JH
    Fertil Steril; 2015 Sep; 104(3):559-60. PubMed ID: 26187299
    [No Abstract]   [Full Text] [Related]  

  • 15. Can vitamin D reduce the risk of uterine fibroids?
    Al-Hendy A; Badr M
    Womens Health (Lond); 2014 Jul; 10(4):353-8. PubMed ID: 25259897
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).
    Vafaei S; Ciebiera M; Omran MM; Ghasroldasht MM; Yang Q; Leake T; Wolfe R; Ali M; Al-Hendy A
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Emerging Treatment Options for Uterine Fibroids.
    Ali M; Ciebiera M; Wlodarczyk M; Alkhrait S; Maajid E; Yang Q; Hsia SM; Al-Hendy A
    Drugs; 2023 Dec; 83(18):1649-1675. PubMed ID: 37922098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum vitamin D status and uterine leiomyomas: a case-control study.
    Okoro CC; Ikpeze OC; Eleje GU; Udigwe GO; Ezeama CO; Ugboaja JO; Enechukwu CI; Umeononihu OS; Ogabido CA; Oguejiofor CB; Njoku TK; Egeonu RO; Okafor CG; Obiagwu HI; Onyejiaka CC; Obidike AB; Onah CE; Uzukwu I; Okoro AD; Ezema EC; Ibekwe AM; Ikechebelu JI
    Obstet Gynecol Sci; 2024 Jan; 67(1):101-111. PubMed ID: 37848168
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.